Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vitro
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2019
Report date:
2019

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: OCDE 442E
GLP compliance:
yes (incl. QA statement)
Type of study:
other: In vitro skin sensitisation

Test material

Constituent 1
Chemical structure
Reference substance name:
Haematoxylin
EC Number:
208-237-3
EC Name:
Haematoxylin
Cas Number:
517-28-2
Molecular formula:
C16H14O6
IUPAC Name:
haematoxylin
Specific details on test material used for the study:
Identification: Hematoxylin HPL
Batch: 007766
Purity: 81.6%
Partition coefficient (n-octanol/water): log Pow: <0.3
Water solubility: App. 19 g/L
Appearance: Light reddish-brown, solid (powder)
Expiry Date: January 2019
Storage Conditions: At room temperature, light protected
Stability in Solvent: Unstable in water
Purpose of Use: Biological stain

Results and discussion

In vitro / in chemico

Resultsopen allclose all
Key result
Run / experiment:
other: first and second runs
Parameter:
other: RFI of CD86 (%)
Remarks:
in at least one concentration
Value:
150
Vehicle controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: Due to strong cytotoxicity observed at the three highest test item concentrations of the first and second h-CLAT run, a confirmatory third run was conducted with adjusted test item concentrations.
Key result
Run / experiment:
other: First and second runs
Parameter:
other: RFI of CD54(%)
Remarks:
in at least one concentration
Value:
200
Vehicle controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: Due to strong cytotoxicity observed at the three highest test item concentrations of the first and second h-CLAT run, a confirmatory third run was conducted with adjusted test item concentrations.
Key result
Run / experiment:
other: Third run
Parameter:
other: RFI of CD86 (%)
Remarks:
in at lest one concentration
Value:
150
Vehicle controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of skin sensitisation
Key result
Run / experiment:
other: Third run
Parameter:
other: RFI of CD54 (%)
Remarks:
in at least one concentration
Value:
200
Vehicle controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of skin sensitisation

Applicant's summary and conclusion

Conclusions:
The test item Hematoxylin HPL with a log Pow of < 0.3 activated THP-1 cells under the test conditions of this study. Therefore the test item is considered positive for the third key event of the skin sensitisation Adverse Outcome Pathway (AOP).